Anne-Laure Mathieu1, Estelle Verronese2, Gillian I Rice3, Fanny Fouyssac4, Yves Bertrand5, Capucine Picard6, Marie Chansel7, Jolan E Walter8, Luigi D Notarangelo9, Manish J Butte10, Kari Christine Nadeau10, Krisztian Csomos8, David J Chen11, Karin Chen12, Ana Delgado2, Chantal Rigal2, Christine Bardin2, Catharina Schuetz13, Despina Moshous7, Héloïse Reumaux14, François Plenat15, Alice Phan16, Marie-Thérèse Zabot17, Brigitte Balme18, Sébastien Viel19, Jacques Bienvenu19, Pierre Cochat16, Mirjam van der Burg20, Christophe Caux2, E Helen Kemp21, Isabelle Rouvet17, Christophe Malcus22, Jean-Francois Méritet23, Annick Lim24, Yanick J Crow3, Nicole Fabien25, Christine Ménétrier-Caux2, Jean-Pierre De Villartay7, Thierry Walzer1, Alexandre Belot26. 1. CIRI, International Center for Infectiology Research, Université de Lyon, Lyon, France; Inserm U1111, Lyon, France; Ecole Normale Supérieure de Lyon, Lyon, France; CNRS, UMR5308, Lyon, France. 2. Université de Lyon, INSERM U1052, Centre de Recherche en Cancérologie de Lyon, Plateforme d'Innovation en Immuno-monitoring et Immunothérapie, Centre Léon Bérard, and in the framework of the LABEX DevWeCan (ANR-10-LABX-0061) of University de Lyon, within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency (ANR), Lyon, France. 3. Manchester Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, Manchester Academic Health Centre, Manchester, United Kingdom. 4. Pediatric Haematology and Oncology Department, Children Hospital-CHU NANCY Vandoeuvre les Nancy, Nancy, France. 5. Institut d'Hématologie et d'Oncologie Pédiatrique (Hospices Civils de Lyon), Université Claude Bernard Lyon I, Lyon, France. 6. Study Center for Primary Immunodeficiencies, Assistance Publique-Hôpitaux de Paris, Necker Hospital, Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Sorbonne Paris Cité, Paris Descartes University, Imagine Institute, Paris Descartes University, Paris, France. 7. INSERM UMR 1163, Laboratoire Dynamique du Génome et Système Immunitaire Université Paris Descartes-Sorbonne Paris Cité, Imagine Institute, Paris, France. 8. Pediatric Allergy & Immunology and the Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Mass. 9. Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, Mass. 10. Department of Pediatrics, Division of Immunology, Allergy and Rheumatology, Stanford University, Stanford, Calif. 11. Division of Molecular Radiation Biology Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Tex. 12. Department of Pediatrics, Division of Allergy, Immunology & Rheumatology, University of Utah School of Medicine, Salt Lake City, Utah. 13. Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany. 14. Pediatric Rheumatology and Emergency Unit, Jeanne de Flandre Hospital, Lille, France. 15. Pathology Department, Hémato-Oncologie Pédiatrique, CHU Nancy, Nancy, France. 16. Pediatric Rheumatology, Nephrology and Dermatology Department and EPICIME Hospices Civils de Lyon and Université Claude-Bernard Lyon 1, Lyon, France. 17. Biotechnology Department, Hospices Civils de Lyon, Lyon, France. 18. Pathology Department, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France. 19. CIRI, International Center for Infectiology Research, Université de Lyon, Lyon, France; Inserm U1111, Lyon, France; Ecole Normale Supérieure de Lyon, Lyon, France; CNRS, UMR5308, Lyon, France; Immunobiology Department, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Lyon, France. 20. Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. 21. Department of Human Metabolism, University of Sheffield, Sheffield, United Kingdom. 22. Cell Immunology Department, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France. 23. Virology Unit, Hopital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France. 24. Immunoscope Group, Immunology Department, Institut Pasteur, Paris, France. 25. Immunobiology Department, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Lyon, France. 26. CIRI, International Center for Infectiology Research, Université de Lyon, Lyon, France; Inserm U1111, Lyon, France; Ecole Normale Supérieure de Lyon, Lyon, France; CNRS, UMR5308, Lyon, France; Pediatric Rheumatology, Nephrology and Dermatology Department and EPICIME Hospices Civils de Lyon and Université Claude-Bernard Lyon 1, Lyon, France. Electronic address: alexandre.belot@chu-lyon.fr.
Abstract
BACKGROUND: PRKDC encodes for DNA-dependent protein kinase catalytic subunit (DNA-PKcs), a kinase that forms part of a complex (DNA-dependent protein kinase [DNA-PK]) crucial for DNA double-strand break repair and V(D)J recombination. In mice DNA-PK also interacts with the transcription factor autoimmune regulator (AIRE) to promote central T-cell tolerance. OBJECTIVE: We sought to understand the causes of an inflammatory disease with granuloma and autoimmunity associated with decreasing T- and B-cell counts over time that had been diagnosed in 2 unrelated patients. METHODS: Genetic, molecular, and functional analyses were performed to characterize an inflammatory disease evocative of a combined immunodeficiency. RESULTS: We identified PRKDC mutations in both patients. These patients exhibited a defect in DNA double-strand break repair and V(D)J recombination. Whole-blood mRNA analysis revealed a strong interferon signature. On activation, memory T cells displayed a skewed cytokine response typical of TH2 and TH1 but not TH17. Moreover, mutated DNA-PKcs did not promote AIRE-dependent transcription of peripheral tissue antigens in vitro. The latter defect correlated in vivo with production of anti-calcium-sensing receptor autoantibodies, which are typically found in AIRE-deficient patients. In addition, 9 months after bone marrow transplantation, patient 1 had Hashimoto thyroiditis, suggesting that organ-specific autoimmunity might be linked to nonhematopoietic cells, such as AIRE-expressing thymic epithelial cells. CONCLUSION: Deficiency of DNA-PKcs, a key AIRE partner, can present as an inflammatory disease with organ-specific autoimmunity, suggesting a role for DNA-PKcs in regulating autoimmune responses and maintaining AIRE-dependent tolerance in human subjects.
BACKGROUND: PRKDC encodes for DNA-dependent protein kinase catalytic subunit (DNA-PKcs), a kinase that forms part of a complex (DNA-dependent protein kinase [DNA-PK]) crucial for DNA double-strand break repair and V(D)J recombination. In mice DNA-PK also interacts with the transcription factor autoimmune regulator (AIRE) to promote central T-cell tolerance. OBJECTIVE: We sought to understand the causes of an inflammatory disease with granuloma and autoimmunity associated with decreasing T- and B-cell counts over time that had been diagnosed in 2 unrelated patients. METHODS: Genetic, molecular, and functional analyses were performed to characterize an inflammatory disease evocative of a combined immunodeficiency. RESULTS: We identified PRKDC mutations in both patients. These patients exhibited a defect in DNA double-strand break repair and V(D)J recombination. Whole-blood mRNA analysis revealed a strong interferon signature. On activation, memory T cells displayed a skewed cytokine response typical of TH2 and TH1 but not TH17. Moreover, mutated DNA-PKcs did not promote AIRE-dependent transcription of peripheral tissue antigens in vitro. The latter defect correlated in vivo with production of anti-calcium-sensing receptor autoantibodies, which are typically found in AIRE-deficient patients. In addition, 9 months after bone marrow transplantation, patient 1 had Hashimoto thyroiditis, suggesting that organ-specific autoimmunity might be linked to nonhematopoietic cells, such as AIRE-expressing thymic epithelial cells. CONCLUSION: Deficiency of DNA-PKcs, a key AIRE partner, can present as an inflammatory disease with organ-specific autoimmunity, suggesting a role for DNA-PKcs in regulating autoimmune responses and maintaining AIRE-dependent tolerance in human subjects.
Authors: E Andrès; F X Limbach; J E Kurtz; V Kurtz-Illig; T Schaeverbeke; F Pflumio; J L Kuntz; J Sibilia Journal: Am J Med Date: 2001-10-15 Impact factor: 4.965
Authors: Patrizia Scapini; Yongmei Hu; Ching-Liang Chu; Thi-Sau Migone; Anthony L Defranco; Marco A Cassatella; Clifford A Lowell Journal: J Exp Med Date: 2010-07-12 Impact factor: 14.307
Authors: Jolan E Walter; Francesca Rucci; Laura Patrizi; Mike Recher; Stephan Regenass; Tiziana Paganini; Marton Keszei; Itai Pessach; Philipp A Lang; Pietro Luigi Poliani; Silvia Giliani; Waleed Al-Herz; Morton J Cowan; Jennifer M Puck; Jack Bleesing; Tim Niehues; Catharina Schuetz; Harry Malech; Suk See DeRavin; Fabio Facchetti; Andrew R Gennery; Emma Andersson; Naynesh R Kamani; JoAnn Sekiguchi; Hamid M Alenezi; Javier Chinen; Ghassan Dbaibo; Gehad ElGhazali; Adriano Fontana; Srdjan Pasic; Cynthia Detre; Cox Terhorst; Frederick W Alt; Luigi D Notarangelo Journal: J Exp Med Date: 2010-06-14 Impact factor: 14.307
Authors: Lisa Woodbine; Jessica A Neal; Nanda-Kumar Sasi; Mayuko Shimada; Karen Deem; Helen Coleman; William B Dobyns; Tomoo Ogi; Katheryn Meek; E Graham Davies; Penny A Jeggo Journal: J Clin Invest Date: 2013-06-03 Impact factor: 14.808
Authors: Pietro Luigi Poliani; Fabio Facchetti; Maria Ravanini; Andrew Richard Gennery; Anna Villa; Chaim M Roifman; Luigi D Notarangelo Journal: Blood Date: 2009-05-04 Impact factor: 22.113
Authors: Brigid S Boland; Preet Bagi; Mark A Valasek; John T Chang; Ranier Bustamante; Lisa Madlensky; William J Sandborn; Olivier Harismendy; Samir Gupta Journal: Am J Gastroenterol Date: 2016-05 Impact factor: 10.864
Authors: Yasin Kaymaz; Cliff I Oduor; Hongbo Yu; Juliana A Otieno; John Michael Ong'echa; Ann M Moormann; Jeffrey A Bailey Journal: Mol Cancer Res Date: 2017-05 Impact factor: 5.852
Authors: Jolan E Walter; Jocelyn R Farmer; Zsofia Foldvari; Troy R Torgerson; Megan A Cooper Journal: J Allergy Clin Immunol Pract Date: 2016 Nov - Dec
Authors: David Buchbinder; Fabian Hauck; Michael H Albert; Anita Rack; Shahrzad Bakhtiar; Anna Shcherbina; Elena Deripapa; Kathleen E Sullivan; Ludmila Perelygina; Marc Eloit; Bénédicte Neven; Philippe Pérot; Despina Moshous; Félipe Suarez; Christine Bodemer; Francisco A Bonilla; Louise E Vaz; Alfons L Krol; Christoph Klein; Mikko Seppanen; Diane J Nugent; Jasjit Singh; Hans D Ochs Journal: J Clin Immunol Date: 2019-01-03 Impact factor: 8.317
Authors: Howard H Y Chang; Nicholas R Pannunzio; Noritaka Adachi; Michael R Lieber Journal: Nat Rev Mol Cell Biol Date: 2017-05-17 Impact factor: 94.444